Vaxcyte (PCVX) Retained Earnings (2019 - 2026)
Vaxcyte (PCVX) reported Retained Earnings of -$2.5 billion for Q1 2026, down 61.9% year-over-year from -$6.5 billion in Q1 2025, and down 14.88% quarter-over-quarter from -$2.2 billion in Q4 2025.
Vaxcyte (PCVX) Retained Earnings (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Retained Earnings data on file, last reported at -$2.5 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$2.5 billion, down 61.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.5 billion (down 61.9% YoY), and the FY2025 annual result was -$2.2 billion, down 55.22% from the prior year.
- Retained Earnings retreated to -$2.5 billion in Q1 2026 per PCVX's latest filing, from -$2.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $856000.0 in Q3 2025 and troughed at -$2.5 billion in Q1 2026.
- A 5-year average of -$826.5 million and a median of -$650.9 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings tumbled 4826887.5% in 2022, then jumped 515.83% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$522.1 million in 2022, then soared by 100.03% to $179000.0 in 2023, then sank by 775697.21% to -$1.4 billion in 2024, then sank by 55.22% to -$2.2 billion in 2025, then retreated by 14.88% to -$2.5 billion in 2026.
- Business Quant data shows PCVX's Retained Earnings at -$2.5 billion in Q1 2026, -$2.2 billion in Q4 2025, and $856000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | -2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.48 Bn |
| Dec 31, 2025 | -2.15 Bn |
| Sep 30, 2025 | 856,000.00 |
| Jun 30, 2025 | -1.70 Bn |
| Mar 31, 2025 | -1.53 Bn |
| Dec 31, 2024 | -1.39 Bn |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | -1.15 Bn |
| Mar 31, 2024 | -1.02 Bn |
| Dec 31, 2023 | 179,000.00 |
| Sep 30, 2023 | -743.59 Mn |
| Jun 30, 2023 | -650.93 Mn |
| Mar 31, 2023 | 47,000.00 |
| Dec 31, 2022 | -522.13 Mn |
| Sep 30, 2022 | -657,000.00 |
| Jun 30, 2022 | -386.16 Mn |
| Mar 31, 2022 | -337.63 Mn |
| Dec 31, 2021 | -298.64 Mn |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -8,000.00 |